Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Terminated 1Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Uterine Cervical Neoplasms 1NSCLC 1Lung Neoplasms 1Leukemia, Myeloid, Chronic-Phase 1Endometrial Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1

Interventions

Dasatinib 4nilotinib 3Imatinib Mesylate 3ruxolitinib 2bosutinib 2Tacrolimus 2Mycophenolic Acid 2Methotrexate 2Cyclosporine 2Cyclophosphamide 2venetoclax 1ponatinib 1pembrolizumab 1letermovir 1fludarabine phosphate 1asciminib 1Whole-Body Irradiation 1Vorinostat 1Valganciclovir 1Tyrosine Kinase Inhibitors 1Therapeutics 1Specimen Handling 1Sirolimus 1Polymerase Chain Reaction 1Pharmaceutical Preparations 1Peripheral Blood Stem Cell Transplantation 1Melphalan 1Ganciclovir 1Foscarnet 1Flow Cytometry 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Leukemia, Myeloid, Chronic-Phase × Tyrosine Kinase Inhibitors × Clear all
NCT03817398 2026-05-20

Stopping Tyrosine Kinase Inhibitors in Affecting Treatment-Free Remission in Patients With Chronic Phase Chronic Myeloid Leukemia

Children's Oncology Group

Phase 2 Active not recruiting
110 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡